Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 5,446,000 | 5,378,000 | 3,188,231 | 5,264,787 | 5,313,297 |
| Cost of Goods | 2,545,000 | 2,432,000 | 1,680,867 | 2,488,913 | 2,370,056 |
| Gross Profit | 2,901,000 | 2,946,000 | 1,507,364 | 2,775,874 | 2,943,241 |
| Operating Expenses | 2,274,000 | 2,331,000 | 1,531,623 | 2,466,771 | 2,379,107 |
| Operating Income | 627,000 | 615,000 | -23,392 | 310,017 | 564,190 |
| Interest Expense | 40,000 | 41,000 | 2,598 | 152,034 | 83,288 |
| Other Income | 14,000 | -20,000 | -1,418,201 | 73,328 | 48,602 |
| Pre-tax Income | 601,000 | 554,000 | -1,444,191 | 231,311 | 529,504 |
| Income Tax | 125,000 | 10,000 | -580,214 | -107,610 | 118,663 |
| Net Income Continuous | 476,000 | 544,000 | -863,977 | 338,921 | 410,841 |
| Net Income Discontinuous | 0 | 0 | 1,917,435 | 1,603,885 | 1,313,771 |
| Net Income | $476,000 | $544,000 | $1,053,458 | $1,942,806 | $1,724,612 |
| EPS Basic Total Ops | 0.30 | 0.35 | 0.66 | 1.22 | 1.09 |
| EPS Basic Continuous Ops | 0.30 | 0.35 | -0.54 | 0.21 | 0.26 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | 1.20 | 1.01 | 0.83 |
| EPS Diluted Total Ops | 0.30 | 0.34 | 0.65 | 1.21 | 1.08 |
| EPS Diluted Continuous Ops | 0.30 | 0.34 | -0.54 | 0.21 | 0.26 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | 1.19 | 1.00 | 0.82 |
| EBITDA(a) | $1,063,000 | $1,036,000 | $564,178 | $1,069,745 | $1,255,625 |